Liver cancer risk after HBsAg loss varies sharply by age and cirrhosis, study finds
-
August 7
Annual HCC incidence ranged from 0.03% in patients without cirrhosis who cleared HBsAg before age 50 to 0.62% in those with cirrhosis aged 50 or older.
BROWSE BY TOPICS
Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist
-
August 3
-
by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR
GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.
Bridging the rural divide: Building a motility center in a critical access hospital
-
August 3
-
by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF
“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”
Is professional coaching worth it? A practical guide for early-career gastroenterologists
-
August 3
-
by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG
Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.
The Latest
Liver cancer risk after HBsAg loss varies sharply by age and cirrhosis, study finds
-
by Meg Barbor
Annual HCC incidence ranged from 0.03% in patients without cirrhosis who cleared HBsAg before age 50 to 0.62% in those with cirrhosis aged 50 or older.
The impact of donations to the AGA Research Foundation
-
by AGA
Support from AGA members helped fund a blood test that identified gastric cancer across 809 specimens — no endoscopy required.
Restarting upadacitinib may recapture remission in ulcerative colitis
-
by Doug Brunk
Half of patients withdrawn to placebo lost response during maintenance; among those who restarted, clinical remission at week 144 ranged from 61% to 76% depending on dose.
Psychiatric risks rise before IBD diagnosis
-
by Doug Brunk
A nationwide Swedish study found that patients with inflammatory bowel disease faced an elevated risk of several psychiatric disorders years before diagnosis, with the greatest increase occurring shortly after diagnosis and persisting for at least a decade.
Early antithrombotic restart after gastrointestinal bleeding tied to fewer vascular events
-
by Doug Brunk
Meta-analysis found resumption within seven days reduced major vascular events but increased recurrent bleeding, with no significant mortality difference by timing.
Esophagus
Liver
Small bowel
Stomach
Obesity
Alcohol-related liver disease
Biliary tract cancer
C. diff
Celiac disease
Colorectal cancer
Crohn's disease
Diarrhea and constipation
Diet and nutrition
IBD
Eosinophilic esophagitis
Eosinophilic GI diseases
Esophageal cancer
IBS
Infections
MASLD and MASH
GERD and Barrett’s esophagus
Hepatic encephalopathy
Liver cancer
Pancreatic diseases and conditions
Short bowel syndrome
Ulcerative colitis
Career & professional development
Diversity, equity, and inclusion
Health, wellness, and burnout
Patient advocacy and equity
Practice management
Coding, coverage, and reimbursement
Technology & innovation
Endoscopy